0001123292-21-000156.txt : 20210203 0001123292-21-000156.hdr.sgml : 20210203 20210203175754 ACCESSION NUMBER: 0001123292-21-000156 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210201 FILED AS OF DATE: 20210203 DATE AS OF CHANGE: 20210203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Silver Point Capital L.P. CENTRAL INDEX KEY: 0001332784 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19756 FILM NUMBER: 21587659 BUSINESS ADDRESS: STREET 1: TWO GREENWICH PLAZA, FIRST FLOOR CITY: GREENWICH STATE: CT ZIP: 06830 BUSINESS PHONE: (203) 542-4000 MAIL ADDRESS: STREET 1: TWO GREENWICH PLAZA, FIRST FLOOR CITY: GREENWICH STATE: CT ZIP: 06830 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Shea Robert J CENTRAL INDEX KEY: 0001382617 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19756 FILM NUMBER: 21587660 MAIL ADDRESS: STREET 1: C/O SILVER POINT CAPITAL L.P. STREET 2: TWO GREENWICH PLAZA, FIRST FLOOR CITY: GREENWICH STATE: CT ZIP: 06830 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MULE EDWARD A CENTRAL INDEX KEY: 0001029625 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19756 FILM NUMBER: 21587661 MAIL ADDRESS: STREET 1: C/O SILVER POINT CAPITAL L.P. STREET 2: TWO GREENWICH PLAZA, FIRST FLOOR CITY: GREENWICH STATE: CT ZIP: 06830 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PDL BIOPHARMA, INC. CENTRAL INDEX KEY: 0000882104 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943023969 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 59 DAMONTE RANCH PARKWAY STREET 2: SUITE B-375 CITY: RENO STATE: NV ZIP: 89521 BUSINESS PHONE: 775-832-8500 MAIL ADDRESS: STREET 1: 59 DAMONTE RANCH PARKWAY STREET 2: SUITE B-375 CITY: RENO STATE: NV ZIP: 89521 FORMER COMPANY: FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE DATE OF NAME CHANGE: 19930328 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2021-02-01 0000882104 PDL BIOPHARMA, INC. PDLI 0001332784 Silver Point Capital L.P. TWO GREENWICH PLAZA, FIRST FLOOR GREENWICH CT 06830 0 0 1 0 0001382617 O'Shea Robert J TWO GREENWICH PLAZA, FIRST FLOOR GREENWICH CT 06830 0 0 1 0 0001029625 MULE EDWARD A TWO GREENWICH PLAZA, FIRST FLOOR GREENWICH CT 06830 0 0 1 0 Common Stock 2021-02-01 4 P 0 187061 2.05 A 23970334 D Silver Point Capital, L.P. ("Silver Point") or its wholly owned subsidiaries are the investment managers of Silver Point Capital Fund, L.P., Silver Point Capital Offshore Master Fund, L.P., Silver Point Distressed Opportunities Fund, L.P., Silver Point Distressed Opportunities Offshore Master Fund, L.P., Silver Point Distressed Opportunity Institutional Partners, L.P. and Silver Point Distressed Opportunity Institutional Partners Master Fund (Offshore), L.P. (the "Funds") and, by reason of such status, may be deemed to be the beneficial owner of all of the reported securities held by the Funds. Silver Point Capital Management, LLC ("Management") is the general partner of Silver Point and as a result may be deemed to be the beneficial owner of all securities held by the Funds. Messrs. Edward A. Mule and Robert J. O'Shea are each members of Management and as a result may be deemed to be the beneficial owner of all of the securities held by the Funds. Silver Point, Management and Messrs. Mule and O'Shea disclaim beneficial ownership of the reported securities held by the Funds except to the extent of their pecuniary interests. /s/ Steven Weiser, Authorized Signatory on behalf of Silver Point Capital, L.P. 2021-02-03 /s/ Steven Weiser (as attorney-in-fact on behalf of Edward A Mule, individually) 2021-02-03 /s/ Steven Weiser (as attorney-in-fact on behalf of Robert J. O'Shea, individually) 2021-02-03